Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A11QVV0
Mon, 13.01.2025
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma
HDP-101 is well tolerated to date, with no signs of dose-limiting toxicities
Complete remission observed in one patient from Cohort 5
Proprietary novel payload with a unique mode of action, representing new [ … ]